14631
|
|
|
V-set and transmembrane domain containing 1 |
SIRL-1, SIRL1, UNQ3033 |
|
14632
|
|
|
V-set and transmembrane domain containing 2A |
VSTM2 |
|
14633
|
|
|
V-set and transmembrane domain containing 2B |
- |
|
14634
|
|
|
V-set and transmembrane domain containing 2 like |
C20orf102, dJ1118M15.2 |
|
14635
|
|
|
V-set and transmembrane domain containing 4 |
C10orf72 |
|
14636
|
|
|
V-set and transmembrane domain containing 5 |
C11orf90 |
|
14637
|
|
|
Visual system homeobox 1 |
CAASDS, KTCN, KTCN1, PPCD, PPCD1, PPD, RINX |
Auditory perceptual disorder, Color vision deficiency, Corneal dystrophy, Craniofacial abnormalities, Craniofacial anomalies with anterior segment dysgenesis, Eye abnormalities, Long qt syndrome, Hereditary corneal dystrophy, Keratoconus, Polymorphous corneal dystrophy, Posterior polymorphous corneal dystrophy |
14638
|
|
|
Visual system homeobox 2 |
CHX10, HOX10, MCOP2, MCOPCB3, RET1 |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia, Blindness, Breast cancer, Colobomatous microphthalmia, Congenital cystic eyeball, Crohn disease, Inflammatory bowel disease, Microphthalmia, Microphthalmos, Ocular sarcoidosis, Retinitis pigmentosa, Ulcerative colitis |
14639
|
|
|
Vesicle trafficking 1 |
6orf55, C6orf55, DRG-1, DRG1, HSPC228, LIP5, My012, SBP1 |
|
14640
|
|
|
V-set domain containing T cell activation inhibitor 1 |
B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291, VCTN1 |
|